MORE►
digital product management
Left to right: Steve Wanta, Michelle Williams, Sara Vassar, Salah Boukadoum, Kate Knight, Matt Myers (front), Benjamin Vann (back), Michael Thomas [Photo: Michael Samples]
Collective Impact: ‘Tomorrow belongs to those who can hear it coming.’
by Dallas Innovates | Staff Report | Oct 24, 2018
Roundtable | Our panel talks about what we can do better, right now. In the final installment of the latest Dallas Innovates roundtable series, we look at systemic issues that still need to be addressed, and the areas ripe for innovation. The discussion closes with a look into the future.
Related Articles
Calendar: Not-to-Miss Events for Innovators in Dallas-Fort Worth
Dallas Innovates and Dallas Regional Chamber Open Nominations for AI 75 2026
ORBIS Holds Grand Opening for New Manufacturing Facility in Greenville
Payments Tech Co. Fortis Appoints New CFO and CROO to Drive Next Growth Phase
Quantum Connections Appoints Its Chief Learning Officer, a Retired U.S. Navy Aviator, as Its New CEO
MORE►
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Dallas-Fort Worth is charting its own path in artificial intelligence. From applied AI to research and engineering advances, our region leads in advancing real-world solutions. Behind every breakthrough and solution are the people making it happen....
Ahead of the fifth annual Venture Dallas conference at the George W. Bush Presidential Center, Rachel Racz, Nasdaq Head of Listings for Texas, Southern U.S., and Latin America, and Sam L....
Munck Wilson Mandala proudly announces that Merritt D. Westcott, a nationally recognized leader in biotech patent litigation, has been named chair of the firm’s Life Sciences Practice Group.
With more than 25 years of experience in complex intellectual property disputes and a master’s degree in genetics and molecular biology, Westcott brings unmatched technical fluency and strategic insight to one of the most dynamic areas of law and innovation....
Irving-based registered investment adviser United Capital Financial Advisors has acquired New York City–based Apexium Financial LP, a nationwide RIA with offices in the Northeast, Mid-Atlantic, and Southwest, including Dallas.
Apexium’s team built a successful firm by growing through multiple referral channels, United Capital President Jim Rivers said in an announcement....
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Dallas-Fort Worth is charting its own path in artificial intelligence. From applied AI to research and engineering advances, our region leads in advancing real-world solutions. Behind every breakthrough and solution are the people making it happen....
Ahead of the fifth annual Venture Dallas conference at the George W. Bush Presidential Center, Rachel Racz, Nasdaq Head of Listings for Texas, Southern U.S., and Latin America, and Sam L....
Munck Wilson Mandala proudly announces that Merritt D. Westcott, a nationally recognized leader in biotech patent litigation, has been named chair of the firm’s Life Sciences Practice Group.
With more than 25 years of experience in complex intellectual property disputes and a master’s degree in genetics and molecular biology, Westcott brings unmatched technical fluency and strategic insight to one of the most dynamic areas of law and innovation....
Irving-based registered investment adviser United Capital Financial Advisors has acquired New York City–based Apexium Financial LP, a nationwide RIA with offices in the Northeast, Mid-Atlantic, and Southwest, including Dallas.
Apexium’s team built a successful firm by growing through multiple referral channels, United Capital President Jim Rivers said in an announcement....
